TY  - JOUR
PB  - BioMed Central
A1  - Rieber, Juliane
A1  - Tonndorf-Martini, Eric
A1  - Schramm, Oliver
A1  - Rhein, Bernhard
A1  - König, Laila
A1  - Adeberg, Sebastian
A1  - Meyerhof, Eva
A1  - Mohr, Angela
A1  - Kappes, Jutta
A1  - Hoffmann, Hans
A1  - Debus, Jürgen
A1  - Rieken, Stefan
TI  - Establishing stereotactic body radiotherapy with flattening filter free techniques in the treatment of pulmonary lesions - initial experiences from a single institution
SP  - 1
IS  - 80
CY  - London
VL  - 11
N2  - Background: Stereotactic body radiotherapy (SBRT) using flattening filter free (FFF)-techniques has been increasingly applied during the last years. However, clinical studies investigating this emerging technique are still rare. Hence, we analyzed toxicity and clinical outcome of pulmonary SBRT with FFF-techniques and performed dosimetric comparison to conventional techniques using flattening filters (FF).   Materials and methods: Between 05/2014 and 06/2015, 56 consecutive patients with 61 pulmonary lesions were treated with SBRT in FFF-mode. Central lesions received 8?×?7.5 Gy delivered to the conformally enclosing 80%-isodose, while peripheral lesions were treated with 3?×?15 Gy, prescribed to the 65%-isodose. Early and late toxicity (after 6 months) as well as initial clinical outcomes were evaluated. Furthermore, [deleted] plan quality and efficiency were evaluated by analyzing conformity, beam- on and total treatment delivery times in comparison to plans with FF-dose application.   Results: Median follow-up time was 9.3 months (range 1.5?18.0 months). Early toxicity was low with only 5 patients (8.9 %) reporting CTCAE 2° or higher side-effects. Only one patient (1.8 %) was diagnosed with radiation-induced pneumonitis CTCAE 3°, while 2 (3.6 %) patients suffered from pneumonitis CTCAE 2°. After 6 months, no toxicity greater than CTCAE 2° was reported. 1-year local progression-free survival, distant progression-free survival and overall survival were 92.8 %, 78.0 %, and 94.4 %, respectively. While plan quality was similar for FFF- and FF-plans in respect to conformity (p?=?0.275), median beam-on time as well as total treatment time were significantly reduced for SBRT in FFF-mode compared to FF-mode (p???0.001, p???0.001).   Conclusions: Patient treatment with SBRT using FFF-techniques is safe and provides promising clinical results with only modest toxicity at significantly increased dose delivery speed.
AV  - public
Y1  - 2016///
EP  - 8
JF  - Radiation Oncology
SN  - 1748-717X
ID  - heidok21524
UR  - https://archiv.ub.uni-heidelberg.de/volltextserver/21524/
ER  -